Louise F. Momparler - Concepedia

Concepedia

Author

Louise F. Momparler

Université de Montréal

Also Known As

L F Momparler, L.F. Momparler, LOUISE F MOMPARLER, Louise F Momparler, Louise F. Momparler, Louise Momparler

43

Publications

1.6K

Citations

23

H-Index

40

Concepts

All Affiliations

Université de Montréal Centre Hospitalier Universitaire Sainte-Justine New York University Abu Dhabi National Cancer Institute Institut National de la Recherche Scientifique

LF

About

Louise F. Momparler is an author at Université de Montréal specializing in medicine, pharmacology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	18	922
2	Cell Biology	9	9	357
3	Natural Sciences	2	2	77
4	Biochemistry	2	2	77
5	Health Sciences	1	1	35

Louise F. Momparler

×

29

Publications

1.6K

Citations

23

H-Index

	Year	Citations
Pilot phase l-ll study on 5-aza-2??-deoxycytidine (Decitabine) in patients with metastatic lung cancer Richard L. Momparler, David Y. Bouffard, Louise F. Momparler, Anti-Cancer Drugs	1997	212
Phase I study on 5-aza-2′-deoxycytidine in children with acute leukemia Georges E. Rivard, Richard L. Momparler, Jocelyn Demers, Leukemia Research Hematological MalignancyOncologyMedicineMixed-phenotype Acute LeukemiaHematology	1981	180
Preclinical evaluation of antineoplastic activity of inhibitors of DNA methylation (5-aza-2′-deoxycytidine) and histone deacetylation (trichostatin A, depsipeptide) in combination against myeloid leukemic cells Sepideh Shaker, Mark L. Bernstein, Louise F. Momparler, Leukemia Research Hematological MalignancyMedicinal ChemistryOncologyMedicineDna Methylation	2003	103
Enhancement of antineoplastic action of 5-aza-2???-deoxycytidine by zebularine on L1210 leukemia Maryse Lemaire, Louise F. Momparler, Mark L. Bernstein, Anti-Cancer Drugs	2005	94
Comparison of the antileukemic activity of 5-aza-2′-deoxycytidine, 1-β-d-arabinofuranosylcytosine and 5-azacytidine against L1210 leukemia Richard L. Momparler, Louise F. Momparler, Johanne Samson Leukemia Research Hematological MalignancyMedicinal ChemistryOncologyL1210 LeukemiaAntiviral Compound	1984	86
Epigenetic therapy of acute myeloid leukemia using 5-aza-2'-deoxycytidine (decitabine) in combination with inhibitors of histone methylation and deacetylation Richard L. Momparler, Sylvie Côté, Louise F. Momparler, Clinical Epigenetics	2014	75
DNA methylation of retinoic acid receptor β in breast cancer and possible therapeutic role of 5-aza-2ʼ-deoxycytidine Veronica Bovenzi, Ngoc Loan Oanh Lê, Sylvie Côté, Anti-Cancer Drugs	1999	74
Antineoplastic action of 5-aza-2′-deoxycytidine and phenylbutyrate on human lung carcinoma cells Anne-Julie Boivin, Louise F. Momparler, Annie Hurtubise, Anti-Cancer Drugs Histone ModificationsEpigenetic ChangePathologyEpigeneticsTumor Biology	2002	69
Importance of dose-schedule of 5-aza-2'-deoxycytidine for epigenetic therapy of cancer Maryse Lemaire, Guy G. Chabot, Noël J.‐M. Raynal, BMC Cancer Hematological MalignancyTumor BiologyGlobal Dna MethylationOncologyOncogenic Agent	2008	65
Inhibition of cytidine deaminase by zebularine enhances the antineoplastic action of 5-aza-2′-deoxycytidine Maryse Lemaire, Louise F. Momparler, Noël J.‐M. Raynal, Cancer Chemotherapy and Pharmacology Molecular PharmacologyMedicinal ChemistryCytidine DeaminaseBiochemistryMedicine	2008	58

Page 1